These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24952242)

  • 1. What about Alice? Peripheral neuropathy from taxane-containing treatment for advanced nonsmall cell lung cancer.
    Bridges CM; Smith EM
    Support Care Cancer; 2014 Sep; 22(9):2581-92. PubMed ID: 24952242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-reported neuropathy and taxane-associated symptoms in a phase 3 trial of nab-paclitaxel plus carboplatin versus solvent-based paclitaxel plus carboplatin for advanced non-small-cell lung cancer.
    Hirsh V; Okamoto I; Hon JK; Page RD; Orsini J; Sakai H; Zhang H; Renschler MF; Socinski MA
    J Thorac Oncol; 2014 Jan; 9(1):83-90. PubMed ID: 24346096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Exploratory Randomized Trial of Physical Therapy for the Treatment of Chemotherapy-Induced Peripheral Neuropathy.
    Andersen Hammond E; Pitz M; Steinfeld K; Lambert P; Shay B
    Neurorehabil Neural Repair; 2020 Mar; 34(3):235-246. PubMed ID: 31976819
    [No Abstract]   [Full Text] [Related]  

  • 4. The prognostic role of the class III β-tubulin in non-small cell lung cancer (NSCLC) patients receiving the taxane/vinorebine-based chemotherapy: a meta-analysis.
    Yang YL; Luo XP; Xian L
    PLoS One; 2014; 9(4):e93997. PubMed ID: 24705847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.
    Kleckner IR; Kamen C; Gewandter JS; Mohile NA; Heckler CE; Culakova E; Fung C; Janelsins MC; Asare M; Lin PJ; Reddy PS; Giguere J; Berenberg J; Kesler SR; Mustian KM
    Support Care Cancer; 2018 Apr; 26(4):1019-1028. PubMed ID: 29243164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of chemotherapy-induced peripheral neuropathy in large population-based cohorts of elderly patients with breast, ovarian, and lung cancer.
    Nurgalieva Z; Xia R; Liu CC; Burau K; Hardy D; Du XL
    Am J Ther; 2010; 17(2):148-58. PubMed ID: 19417586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring the side effects of taxane therapy in oncology: the functional assesment of cancer therapy-taxane (FACT-taxane).
    Cella D; Peterman A; Hudgens S; Webster K; Socinski MA
    Cancer; 2003 Aug; 98(4):822-31. PubMed ID: 12910528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study of halichondrin B analog eribulin mesylate (E7389) in patients with advanced non-small cell lung cancer previously treated with a taxane: a California cancer consortium trial.
    Gitlitz BJ; Tsao-Wei DD; Groshen S; Davies A; Koczywas M; Belani CP; Argiris A; Ramalingam S; Vokes EE; Edelman M; Hoffman P; Ballas MS; Liu SV; Gandara DR
    J Thorac Oncol; 2012 Mar; 7(3):574-8. PubMed ID: 22198425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized phase III PITCAP trial and meta-analysis of induction chemotherapy followed by thoracic irradiation with or without concurrent taxane-based chemotherapy in locally advanced NSCLC.
    Ardizzoni A; Tiseo M; Boni L; Di Maio M; Buffoni L; Belvedere O; Grossi F; D'Alessandro V; de Marinis F; Barbera S; Caroti C; Favaretto A; Cortinovis D; Morrica B; Tixi L; Ceschia T; Parisi S; Ricardi U; Grimaldi A; Loreggian L; Navarria P; Huber RM; Belani C; Brunsvig PF; Scagliotti GV; Scolaro T
    Lung Cancer; 2016 Oct; 100():30-37. PubMed ID: 27597278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling.
    Kolb NA; Smith AG; Singleton JR; Beck SL; Stoddard GJ; Brown S; Mooney K
    JAMA Neurol; 2016 Jul; 73(7):860-6. PubMed ID: 27183099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole genome sequencing across clinical trials identifies rare coding variants in GPR68 associated with chemotherapy-induced peripheral neuropathy.
    Khan Z; Jung M; Crow M; Mohindra R; Maiya V; Kaminker JS; Hackos DH; Chandler GS; McCarthy MI; Bhangale T
    Genome Med; 2023 Jun; 15(1):45. PubMed ID: 37344884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors.
    Eckhoff L; Knoop A; Jensen MB; Ewertz M
    Eur J Cancer; 2015 Feb; 51(3):292-300. PubMed ID: 25541155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term peripheral neuropathy symptoms in breast cancer survivors.
    Mustafa Ali M; Moeller M; Rybicki L; Moore HCF
    Breast Cancer Res Treat; 2017 Nov; 166(2):519-526. PubMed ID: 28791499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variants predictive of chemotherapy-induced peripheral neuropathy symptoms in gynecologic cancer survivors.
    Thomaier L; Darst BF; Jewett P; Hoffmann C; Brown K; Makaram A; Blaes A; Argenta P; Teoh D; Vogel RI
    Gynecol Oncol; 2021 Dec; 163(3):578-582. PubMed ID: 34674889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taxane-platinum combinations in advanced non-small cell lung cancer: a review.
    Rigas JR
    Oncologist; 2004; 9 Suppl 2():16-23. PubMed ID: 15161987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy-induced peripheral neuropathy in newly diagnosed breast cancer survivors treated with taxane: a prospective longitudinal study.
    Wang YJ; Chan YN; Jheng YW; Wu CJ; Lin MW; Tseng LM; Tsai YF; Liu LC
    Support Care Cancer; 2021 Jun; 29(6):2959-2971. PubMed ID: 33025227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221).
    Mongiovi JM; Zirpoli GR; Cannioto R; Sucheston-Campbell LE; Hershman DL; Unger JM; Moore HCF; Stewart JA; Isaacs C; Hobday TJ; Salim M; Hortobagyi GN; Gralow JR; Thomas Budd G; Albain KS; Ambrosone CB; McCann SE
    Breast Cancer Res; 2018 Nov; 20(1):146. PubMed ID: 30486865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taxanes as first-line therapy for advanced non-small cell lung cancer: a systematic review and practice guideline.
    Chu Q; Vincent M; Logan D; Mackay JA; Evans WK;
    Lung Cancer; 2005 Dec; 50(3):355-74. PubMed ID: 16139391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taxane-induced peripheral sensorial neuropathy in cancer patients is associated with duration of diabetes mellitus: a single-center retrospective study.
    Kus T; Aktas G; Kalender ME; Sevinc A; Kul S; Suner A; Ulker E; Camci C
    Support Care Cancer; 2016 Mar; 24(3):1175-9. PubMed ID: 26279147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects of Ganglioside-Monosialic Acid in Taxane-Induced Peripheral Neurotoxicity in Patients with Breast Cancer: A Randomized Trial.
    Su Y; Huang J; Wang S; Unger JM; Arias-Fuenzalida J; Shi Y; Li J; Gao Y; Shi W; Wang X; Peng R; Xu F; An X; Xue C; Xia W; Hong R; Zhong Y; Lin Y; Huang H; Zhang A; Zhang L; Cai L; Zhang J; Yuan Z
    J Natl Cancer Inst; 2020 Jan; 112(1):55-62. PubMed ID: 31093677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.